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Abstract: Idiopathic scoliosis (AIS) is the most common pediatric spinal deformity, affecting ~3% of children worldwide. 
AIS significantly impacts national health in the U. S. alone, creating disfigurement and disability for over 10% of patients 
and costing billions of dollars annually for treatment. Despite many investigations, the underlying etiology of IS is poorly 
understood. Twin studies and observations of familial aggregation reveal significant genetic contributions to IS. Several 
features of the disease including potentially strong genetic effects, the early onset of disease, and standardized diagnostic 
criteria make IS ideal for genomic approaches to finding risk factors. Here we comprehensively review the genetic contri-
butions to IS and compare those findings to other well-described complex diseases such as Crohn’s disease, type 1 diabe-
tes, psoriasis, and rheumatoid arthritis. We also summarize candidate gene studies and evaluate them in the context of 
possible disease aetiology. Finally, we provide study designs that apply emerging genomic technologies to this disease. 
Existing genetic data provide testable hypotheses regarding IS etiology, and also provide proof of principle for applying 
high-density genome-wide methods to finding susceptibility genes and disease modifiers.  
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INTRODUCTION 
  “Scoliosis”, derived from the Greek word for crooked, 
describes a lateral “S-shaped” spinal deformity. Various 
pathological conditions can present with an associated scoli-
osis in humans. For example, scoliosis may be secondary to 
neuromuscular/neurological disease such as Duchenne’s 
muscular dystrophy, spinal muscular atrophy, or polio. In 
other cases the spinal deformity is a direct result of vertebral 
anomalies that are easily visualized by radiography and typi-
cally present at birth. However, most scoliosis develops in 
apparent isolation in an otherwise healthy, pre-adolescent 
child (Fig. (1)). This “idiopathic” form of scoliosis is typi-
cally observed during two periods of rapid growth, at infancy 
and the onset of adolescence. The great majority of cases are 
of adolescent onset. Although estimates vary, adolescent 
idiopathic scoliosis (IS) generally affects 2-3% of school age 
children, and it appears that no ethnic population is spared 
[1]. Due to the relatively high frequency and potential risks 
of the disease (see below), many children participate in 
school screenings for the purpose of early detection [2].  
  IS is best described as a three dimensional deformity due 
to rotation of the vertebrae within the curve. Progression of 
this rotational deformity can ultimately evoke pulmonary 
compromise [3]. Otherwise the natural history of untreated 
IS involves increased back pain and spinal osteoarthritis   
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[4,5]. Thus, the central clinical issue in treating IS is antici-
pating and controlling progression of the deformity. Risk 
factors for progression in an affected child are well-
documented [6]. The most obvious IS risk factor is gender. 
Affected girls are at least five times more likely to have pro-
gressive curves as compared to affected boys, but the reasons 
for this are unknown [7]. Other risk factors are initial curve 
pattern, and severity of curvature in relation to remaining 
growth. Certain curve patterns, e.g. in the thoracic region, 
are more likely to progress in severity and therefore must be 
monitored carefully. How growth per se provokes disease 
progression is unclear, but nevertheless the two are highly 
correlated. Because of this relationship, several measures are 
typically used to monitor remaining growth in the child with 
IS. These include menarchal status in girls, bone age, or peak 
height velocity. In the last case, peak height velocity refers to 
the point at which the child is at maximum growth, taken 
from sequential height measurements. Historical data allows 
estimation of this point, beyond which the child is at lesser 
risk for curve progression. If curve progression is minimal or 
controlled through the high-risk period, e.g. by bracing, then 
surgery may be avoided. However, surgery is warranted for 
curves that continue to progress (to a threshold of ~50˚) be-
fore the high-risk period is over [6]. Thus management of IS, 
from screening and monitoring to intervention, is a consider-
able health care burden to patients, families, and clinicians. 
  As will be discussed in this review, many clinical inves-
tigations of IS have revealed interesting phenomena associ-
ated with the disease, but have failed to produce underlying 
susceptibility factors or disease modifiers. Thus the aetiolo- 52    Current Genomics, 2008, Vol. 9, No. 1  Wise et al. 
gical understanding of IS has remained poor (reviewed in 
[8]). More recently, successes in identifying genetic loci un-
derlying common diseases such as inflammatory bowel dis-
ease, psoriasis, age-related macular degeneration, type 2 dia-
betes, and coronary heart disease [9-18] have generated in-
creasing interest in applying similar genome-wide ap-
proaches in large scale studies of IS. Such strategies are ap-
pealing in part because they are agnostic to disease aetiol-
ogy. IS may be particularly amenable to such analyses for 
several reasons. First, as will be discussed quantitatively in 
this review, are its significant genetic underpinnings, estab-
lished by literature going back more than seventy years. Sec-
ond, IS is routinely phenotyped using standardized objective 
measures that reduce clinical heterogeneity and thereby may 
substantially increase power to detect genetic associations. 
Finally, the onset in childhood enables collection of entire 
families that can provide information on linkage, association, 
and inheritance. The recent association of IS susceptibility 
with variants in the CHD7 gene provides proof of concept 
for these approaches. Here we review IS as a complex ge-
netic disease and compare it to other common diseases in 
terms of genetic risk. We discuss candidate susceptibility 
genes and modifier genes in light of recent discoveries. Fi-
nally, we present strategies for genome-wide studies to de-
tect haplotypes and copy number variants underlying IS sus-
ceptibility. New genetic approaches will reveal insights into 
disease pathogenesis and may also uncover risk factors for 
IS susceptibility and progression. 
GENETIC EVIDENCE IN IS 
Is IS genetic?  
  The recognition of genetic influences in IS is well-
documented [19-25]. Familial forms of IS were described as 
early as 1922 [26]. Since then, reports of multiple twin sets 
and twin series have consistently shown higher concordance 
in monozygotic (MZ) compared to dizygotic (DZ) twins (re-
viewed in [27]). A meta-analysis of these clinical twin stud-
ies revealed 73% MZ compared to 36% DZ concordances 
[28]. Interestingly, in this series there was a significant cor-
relation with curve severity in monozygous twins (P<.0002), 
but not dizygous twins. No correlation with curve pattern 
was found, suggesting the importance of genetic factors in 
controlling susceptibility and disease course, but not neces-
sarily disease pattern. More recently, Andersen et al. [29] 
reported their findings using the Danish Twin Registry. They 
found 25% proband-wise concordance in monozygotic twins 
(6 of 44 concordant) compared to 0% concordance (0 of 91) 
in dizygotic twins, with an overall prevalence of approxi-
mately 1%. The lower concordances in both groups as com-
pared with prior results may be explained by differences in 
study design, specifically, ascertainment in clinics versus by 
registry, and screening by examination versus questionnaire. 
Nevertheless the overall trend obtained for all studies sug-
gests strong genetic effects in IS. Interestingly, measured 
concordances in monozygotic twins were below 100%, re-
flecting the complexity of disease and suggesting the in-
volvement of as yet unknown environmental or stochastic 
factors in disease susceptibility.  
How is IS Susceptibility Inherited?  
  Given that genes contribute to IS, how is disease suscep-
tibility inherited? Autosomal dominant inheritance has been 
suggested [19-26] from evaluation of single families or small 
family collections (Fig. (2)). X-linked dominant inheritance 
has been a prevailing theory to explain apparent lack of 
male-male transmission [22]. However this was disputed 
after re-evaluation of X ray data from original study subjects 
[23, 27]). Various studies have found that IS disease risk 
falls off quickly comparing first-degree relatives of a 
proband to subsequent generations. Other studies found simi-
lar trends [23-25]. Specifically, in their comprehensive popu-
lation study Riseborough et al. reported overall risk to first-
degree relatives of 11% compared to 2.4% and 1.4% in sec-
ond- and third-degree relatives [23]. Interestingly, some but 
not all studies have found advanced maternal age for moth-
ers of probands with IS [23-25, 30]. These observations may 
be most consistent with a multifactorial inheritance model 
involving several to many genes, interplaying with unknown 
environmental factors. The general consensus gathered from 
all of this is that, while families with dominant inheritance 
may exist, IS is generally a “complex” genetic disease that is 
not easily explained by existing inheritance models.  
 
 
 
 
 
 
 
 
 
Fig. (1). IS in an adolescent female. Physical examination reveals a rib hump on forward bending (left-most panels). X rays on the right 
reveal a right thoracic curve measuring 57 degrees but without vertebral or other structural anomalies. Understanding Genetic Factors in Idiopathic Scoliosis  Current Genomics, 2008, Vol. 9, No. 1    53 
  Here it may be useful to consider insights derived from 
studies of other so-called complex diseases. For example, de 
novo copy number variation was recently described in ~10% 
of sporadic cases of autism spectrum disorders, also de-
scribed as complex genetic disease of childhood [31]. From 
this observation the authors proposed a model of autism in-
heritance in which a minority of cases is explained by highly 
penetrant, dominantly inherited alleles. Remaining cases 
were explained by sporadic mutations that are highly pene-
trant in males but not females. In this model, familial (domi-
nantly inherited) cases initiate from sporadic females that are 
largely unaffected but carry genetically predisposing alleles 
[32]. Although autism differs from IS in gender distribution 
and fecundity (IS affected individuals are normal in this re-
gard), as noted IS is described as mostly sporadic and some-
times dominant. Future genomic analysis of IS may shed 
insight into this issue. In the meantime, as described later in 
this review, the specification of inheritance model is useful 
but not requisite for genomic studies aimed at discovering 
underlying disease alleles. 
What Influences Disease Progression?  
  As noted, IS disease severity has been correlated in 
monozygotic twins. This suggests that genetic factors are 
important not only in IS susceptibility, but also as disease 
modifiers. However, the variability in disease course typi-
cally observed within families suggests that such IS modifier 
genes are, in general, distinct from susceptibility genes. En-
vironmental factors, perhaps the hormonal milieu, may also 
influence disease course but this area remains largely unex-
plored.  
How “Genetic” is IS Compared to other Common and 
Complex Diseases?  
  Familial risk values may be used to estimate and compare 
the genetic effects across diseases. Prior sibling risk studies 
of IS have reported 19% and 11.5% of siblings affected for  
10,  20-degree curves, respectively, compared to population 
recurrence risks of  2% [23, 33, 34]. In a cohort of 305 IS 
families we found 16% of siblings affected (unpublished 
data) and compared these numbers to the incidence of IS in 
the general population in order to estimate the sibling risk 
ratio (s) for IS. This yielded overall s values ranging from 
8-23, dependent on curve severity. These values represent 
significant genetic effects that are comparable to those for 
other well-described complex genetic diseases such as rheu-
matoid arthritis (RA), Crohn’s disease (CD), type 1 diabetes 
(T1D), or psoriasis (Table 1). The possibility of a major gene 
contributing to IS, analogous to human leukocyte antigen 
(HLA) genes in the listed inflammatory diseases, has been 
suggested but remains unproven [39].  
 
Table 1.  Calculated Sibling Risk Ratios for IS are Compara-
ble to Other Well-Studied Complex Genetic Diseases 
We compared the frequency of IS in siblings of probands with IS to 
the frequency of IS in the general population. This produced an 
estimated sibling risk ratio (s) of 8 for curves  15˚ and 23 for 
curves  20˚ 
Disease Prevalence  s Reference 
RA .01  2-17  [35] 
CD .001 10  [36] 
T1D .007  15  [37] 
Psoriasis .02  4-11.5  [38] 
IS (10˚) .03  8 Unpublished  observations 
IS (20˚) .005  23 Unpublished  observations 
 
GENE MAPPING 
Linkage Analyses 
  Statistical methods may be used to “link” polymorphic 
biologic markers with disease. Linkage studies may be con-
ducted in a hypothesis-driven fashion, in which markers in 
specific candidate molecules are tested for linkage with dis-
ease. Early linkage studies of IS were driven by the hypothe-
sis that variation in structural components of the spine could 
be responsible for susceptibility to IS. Polymorphisms in the 
collagen genes COL1A1,  COL1A2, the fibrillin 1 gene 
FBN1, and the elastin gene ELN have been tested in family 
collections, but the results did not reveal evidence of linkage 
[40, 41]. The subsequent availability of anonymous poly-
morphisms across the entire human genome made it possible 
to conduct systematic searches for IS-linked genes without 
formulating prior hypotheses about disease aetiology. The 
 
 
 
 
 
 
 
 
 
 
Fig. (2). IS inheritance in an extended pedigree. Blackened, clear, and gray symbols represent affected, unaffected, and mildly affect (<15° 
curvature) individuals. This family exhibits possible autosomal dominant inheritance of IS with reduced penetrance. 54    Current Genomics, 2008, Vol. 9, No. 1  Wise et al. 
first such genome-wide linkage scan was performed in a 
single family segregating IS in three generations [42]. Sub-
sequent genome-wide scans of IS families and family collec-
tions have been reported [43-47]. These have produced pos-
sible linkages, three of which are designated IS1, IS2, and 
IS3 in Mendelian Inheritance in Man (MIM), an official reg-
istry of genetic disease loci. IS1 (MIM #181800) was linked 
to chromosome 19p13.3 in a collection of seven Asian fami-
lies of southern Chinese descent [44]. IS2 (MIM #607354) 
was linked to chromosome 17p11 in a single Italian family 
segregating IS in an apparent autosomal dominant fashion 
[43]. IS3 (MIM #608765) was linked to chromosome 8q12 
in a single extended pedigree and subsequently confirmed in 
an independent collection of 52 pedigrees [48]. Additionally, 
genome-wide scans in a collection of 202 families produced 
varying results dependent on the stratification of the data. 
Without prior stratification by inheritance model or disease 
severity, suggestive results were reported for regions of 
chromosomes 1 and 6. However with stratification other 
regions became more significant. The authors concluded that 
regions of chromosomes 6, 9, 16, and 17 are primary regions 
of interest warranting further analysis [46]. Reported link-
ages for IS are summarized in Table 2.  
 
Table 2.  Reported Linkages for IS 
Regions proposed to harbor IS susceptibility genes are given by 
cytogenetic location, position relative to known polymorphisms, 
and MIM designation. References a-g refer to citations [42-48], 
respectively.  
Chromosomal 
Region 
OMIM  
Locus 
Flanking Loci  Ref. 
6p   D6S1051-D6S1017  a,  b 
6q   D6S1053-D6S1021  b 
8q IS3 D8S1477-D8S279  c 
9q  D9S938-D9S934  b 
10q   D10S1222-D10S212  a 
16q   D16S764-D16S2624  b 
17p IS2  D17S974-D17S1294  d 
18q   D18S1357-D18S1371  a 
19p IS1  D19S1034  e,  f 
Xq   GATA144D04-GATA172D05  g 
 
Cytogenetic Studies 
  Most genetic diseases are explained by relatively subtle, 
submicroscopic DNA changes [49]. However, the rare cases 
with visible cytogenetic alterations can immediately pinpoint 
causative genes. For example, chromosome 17 rearrange-
ments helped to more precisely localize the NF1 gene re-
sponsible for neurofibromatosis [50]. Many chromosomal 
alterations with phenotypes that include scoliosis have been 
reported, although most do not appear to re-capitulate idio-
pathic forms, i.e., without obvious vertebral anomalies or co-
existing diagnoses. One family segregating a pericentric in-
version of chromosome 8 with idiopathic scoliosis has been 
reported [51]. Using methods of chromosomal breakpoint 
mapping, Bashiardes et al. [52] found that one end of this 
inversion disrupted the 8q11.2 gene encoding gamma-1-
syntrophin (SNTG1), while the other end of the inversion 
occurred in a gene-free region of 8p23. Subsequent analysis 
of the SNTG1 gene in 152 additional IS patients revealed an 
apparent mutation in DNA samples from three unrelated 
patients. These changes were not detected in screens of 480 
healthy control individuals. These results suggested that rare 
mutations in SNTG1 could occur in a small percentage of 
idiopathic scoliosis patients and left open the possibility that 
other nearby genes could be important in IS.  
Identifying Susceptibility Genes 
  Candidate gene studies of IS have been generally unre-
vealing as noted. In a prior linkage study of 53 families our 
group identified a large region of chromosome 8q12 linked 
with IS (locus IS3), apparently near the SNTG1 gene as de-
scribed above. Further study revealed that this signal was 
due at least in part to a different gene encoding the chromo-
domain helicase DNA binding protein 7 (CHD7), that was 
both linked and associated with IS [48]. Specifically, multi-
ple single nucleotide polymorphisms (SNPs) in CHD7 were 
significantly associated with increased risk of developing 
disease. That study also produced additional (previously un-
published) observations. First, SNP associations within 
CHD7 gene were detected for various inheritance models, 
underscoring the difficulty in specifying any single model 
for IS. Also affected members within individual IS families 
typically differed in severity and pattern of disease, possibly 
indicating that disease susceptibility and expression were 
controlled by distinct genetic factors. Alternatively, it is pos-
sible that the presence of disease in other affected family 
members was a phenocopy, or genetically unrelated. When 
these alternative explanations were tested using the FBAT 
statistic that considers all affected members in a pedigree, p-
values were significant for the SNPs used in the previously 
published study (Fig. (3)). These results supported the con-
clusion that presence of disease in siblings in this cohort was 
genetically related, and that separate factors may influence 
severity/disease course.  
CANDIDATE GENES AND IS AETIOLOGY 
  IS, at least superficially, appears to involve spine and 
muscle, and it is therefore perhaps surprising that a neuro-
logical pathogenesis is the prevailing opinion to explain dis-
ease susceptibility [53]. In this scenario, alterations in verte-
bral shape and paraspinal muscles may be secondary reac-
tions to an initial neurologic lesion. This model is derived 
from many observations. For example, scoliosis is often seen 
in association with neurologic/neuromuscular disease as 
noted. There is also a well- documented association between 
apparently isolated scoliosis and spinal cord anomaly such as 
a syrinx. It is unclear in these cases whether scoliosis occurs 
secondary to spinal cord deformity, or whether both deformi-
ties are secondary to another neurological lesion [53]. Defi-
cits in oculovestibular (visual/hearing) and proprioceptive 
function have been implicated in some studies of IS patients 
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ences (reviewed in [8, 34]). In laboratory animals, scoliosis 
may be induced experimentally or by injury. Small lesions in 
the pons or periaqueductal gray matter have produced scolio-
sis in rats and rabbits with low efficiency [8]. Interestingly, 
removal of the pineal gland from chickens, fish, and bipedal 
rats produces scoliosis that resembles IS [54-58]. This effect 
is not seen in quadripeds and suggests that bipedalism/ 
upright posture provokes the deformity. Finally, neurologic 
underpinnings may be supported by rare “extreme” pheno-
types such as the autosomal recessive disease horizontal gaze 
palsy with progressive scoliosis (HGPPS, MIM #607313). 
This disease is caused by homozygous loss of function muta-
tions in the ROBO3 gene encoding a transmembrane recep-
tor controlling axon guidance [59]. Brain imaging studies of 
these patients have confirmed that uncrossed motor and sen-
sory axonal projections are present in the hindbrain. Re-
markably, the only clinical manifestations in HGPPS patients 
are severe scoliosis and absent horizontal eye movement.  
 
 
 
 
 
 
 
 
 
 
Fig. (3). FBAT analysis of 53 families with idiopathic scoliosis. 
Negative log of the associated P-value is plotted on the Y axis ver-
sus ordered polymorphisms in the CHD7 gene along the X axis. 
  How the various neurologic lesions described here could 
precipitate scoliosis is unclear. In the case of HGPPS pa-
tients, the authors hypothesized secondary abrogation of 
muscle tone and locomotion [59]. An effect on melatonin pro-  
duction has been invoked to explain the effect of pinealec-
tomy in animals, and impaired melatonin signaling has been 
reported in osteoblasts derived from IS patients [60]. Re-
cently, a case-control analysis found evidence of allelic asso-
ciation for a tagSNP in the melatonin receptor (MTNR1B) 
promoter region with IS in Asian cohorts [61]. These studies 
suggest that neuroendocrine pathways, perhaps affecting 
vertebral growth, may be important in scoliosis. In the case 
of the IS-associated gene CHD7, loss-of-function coding 
mutations in the gene are known to cause the CHARGE syn-
drome of multiple developmental anomalies that can include 
scoliosis. Milder variants leading to a relative reduction of 
CHD7 protein has been proposed to explain its association 
with IS susceptibility [48]. It is interesting to note that in the 
developing mouse CHD7 is strongly expressed in primary 
epithelial tissues, in particular primordial neuronal tissues, 
with little expression in surrounding mesenchymal tissues. If 
extrapolated to human postnatal development, this expres-
sion pattern suggests IS susceptibility triggered by neu-
rologic pathways rather than via direct effects on structural 
elements, i.e., muscle, bone, and connective tissue.  
  Despite these observations, lesions of ligamentous spine 
or paraspinous muscles or cannot be excluded in IS patho-
genesis. Whereas histochemical and ultrastructural studies of 
cartilage, bone, and growth plate in IS patients have been 
unrevealing [33], an immunohistochemical analysis of the 
ligamentum flavum revealed some disarrangement of fibers 
in IS patients compared to controls [62]. Other studies have 
shown decreased glycosaminoglycan content in the interver-
tebral discs of IS patients (reviewed in [8]). Histochemical 
analyses of paraspinous muscles surrounding the scoliotic 
curve have shown relative hypertrophy and increased elec-
tromyographic signaling of type I fibers on the convexity of 
the curve in IS patients. This was explained as most likely a 
compensatory response to curve progression [8, 34]. Regard-
ing the bony composition of the spinal column itself, many 
studies, mostly in Asian cohorts, report generalized os-
teopenia in IS patients [63-65]. One study found that os-
teopenia of the femoral neck was a prognostic indicator of 
curve progression, with an odds ratio of 2.3 [66]. Association 
between polymorphisms in the estrogen receptor (ESR1) 
gene and curve severity has been reported, again in Asian IS 
cohorts, but other studies have not supported this finding 
[67, 68]. Thus, it is conceivable that genetic variation affect-
ing structural components of the spine may exert quantitative 
effects on curve progression in IS. 
LARGE SCALE STUDIES TO DISCOVER NEW IS 
GENES 
Genome-Wide Studies 
  A priori, we do not know what sort of genetic variation 
will underly IS susceptibility. New methods will eventually 
enable re-sequencing of candidate regions or entire genomes 
to identify causative disease alleles [69, 70]. This will be 
particularly useful for sorting out weak signals produced by 
genetic heterogeneity. In the meantime, chip-based method-
ologies are now enabling efficient genome-wide association 
(GWA) studies to identify disease-associated haplotypes 
within targeted populations [71, 72]. In some instances, a 
genotyped SNP itself may be the culprit, while in other in-
stances the genotyped SNPs simply mark common haplo-
types carrying disease-associated variants. Either way, ge-
netic associations are measured by comparing large sets of 
affected cases to healthy controls to detect differences in 
allele frequencies in the two populations. Unrelated control 
individuals are relatively easily ascertained but can introduce 
bias largely due to population substructure [73]. An alterna-
tive design is family-based and measures the frequencies that 
alleles are transmitted from parents to affected offspring. 
The major benefit of this latter approach is that parents are 
ideal population controls for their children, but this must be 
weighed against ascertainment difficulties, particularly for 
late-onset diseases. With onset early in the second decade of 
life, family-based designs are ideal for genetic studies of IS. 
Thus both case-control and family-based designs should 
prove useful in GWA and follow-up studies of IS. 
  We previously hypothesized that genes responsible for 
rare disorders involving scoliosis may be important in “idio-
pathic” forms of the disease [48]. Some of these rare disor-
ders involve known copy number variation (i.e. duplica-
tion/deletion). For example, scoliosis is well-described as 56    Current Genomics, 2008, Vol. 9, No. 1  Wise et al. 
part of the phenotype in relatively rare duplication/deletion 
syndromes such as Charcot-Marie-Tooth disease [74], 
Smith-Magenis syndrome [75], spinal muscular atrophy [76], 
Di George syndrome [77] and Prader-Willi syndrome [78]. It 
is interesting that copy number polymorphisms have been 
observed within the genomic regions involved in the latter 
three diseases [79, 80]. Whether common copy number vari-
ants are important in scoliosis, particularly IS, is unknown. 
Methods to detect CNV include array comparative genomic 
hybridization (CGH) and quantitative analysis of chip-based 
SNP genotyping [81, 82]. An important consideration here is 
the possibility that de novo CNVs may cause disease as has 
been detected in autism spectrum disorders. It will be inter-
esting to also consider the possibility that dosage (i.e. copy 
number) may correlate with some aspect of disease, such as 
severity or onset, as has been observed, for example, with 
the CMT-associated 17p duplication [74].  
  As noted, genetic factors may be important in disease 
course, i.e. curve progression, in IS. Among the more rele-
vant questions that clinicians have is whether there is some 
way of predicting whether patients with a certain initial cur-
vature will progress to severe scoliosis requiring interven-
tion, or whether they will not progress significantly, so that 
no intervention is required. Several statistical methodologies 
enable use of phenotype and genotype data to investigate 
such questions. For example, survival analysis methods [83] 
with longitudinal data enable us to test whether some com- 
bination of input variables predicts differing times to "se- 
vere" curvature for different patients (e.g., those with a pro-
gressive form of disease as compared with those without). In 
these methods, input variables may include, for example, 
SNP genotypes, gender, ethnicity, and initial measures of 
age, curve magnitude, curve pattern, Risser sign, with out-
come variable being curve magnitude at a later time point. 
Also, recently developed mixture modeling techniques [84, 
85] ask whether a sample of patients' disease progression 
trajectories may be decomposed into homogeneous sub-
groups of trajectories (e.g., patients with rapid progression in 
curvature as compared with those with slow progression in 
curvature), and what input variables classify patients into the 
different sub-groups. In this way it may be possible to iden-
tify combinations of genotypes and phenotypes that classify 
progressive IS.  
  For any genome-wide study, however, possible con-
founding issues must be addressed. The first issue is power 
and the ability to detect true associations. Power in genetic 
studies is a function of the disease risk posed by the SNP 
(genotype relative risk, or GRR), the frequency of SNP vari-
ants in a given population, and the frequency of disease in 
the population [86]. The relatively high frequency of IS (2-
3%) in most (if not all populations) and its strong genetic 
underpinnings relative to other well-studied complex dis-
eases predict good power for genome-wide studies [87]. Es-
timates of power to detect IS susceptibility alleles are given 
in Fig. (4). The second issue is genetic heterogeneity that can 
effectively dilute positive signals. Although we do not know 
a priori the source of such heterogeneity, various stratifica-
tion schemes may be useful to consider in large-scale genetic 
studies of IS. For example, datasets may be stratified by 
gender, age at onset, or curve severity in the proband. Re-
garding gender, male onset is typically later than in females, 
coinciding with the male adolescent growth spurt, and dis-
ease progression continues much later in development, 
through Risser stage 5 of bone growth [7, 88]. Regarding 
severity, other linkage studies of IS have found differences 
when data were stratified by curve severity [45, 46]. Also, 
increasing estimates of s were observed for curves greater 
than 20˚ (Table 1), suggesting greater genetic effect for more 
progressive disease. For all such strategies, however, it will 
be important not to unduly burden the study with multiple 
tests to the point that small gains in statistical significance 
are lost.  
  In any planned genetic study of IS it would seem rational 
to include familial cases of the disease. However, are such 
cases representative of the more common sporadic cases? As 
shown in Table 3, a comparison of sporadic cases to familial 
cases in one cohort revealed no significant differences in 
ethnicity, fraction of male probands, age at first presentation 
 
 
 
 
 
 
 
 
 
Fig. (4). Power to detect and replicate association as a function of genotype relative risk (R1) and disease allele frequency. The analy-
sis assumes a two-stage design as described by Skol et al. [89], although modified so that power is calculated for TDT rather than case-
control sampling. The total sample size is 2,100, with 700 trios included in stage 1 and 1,400 trios included in stage 2. Power is computed 
assuming that the disease locus operates in a multiplicative fashion and for a genome-wide significance of .10.  Understanding Genetic Factors in Idiopathic Scoliosis  Current Genomics, 2008, Vol. 9, No. 1    57 
or severity in affected individuals (P>0.1 in all instances). 
Thus families with multiple cases of IS may provide impor-
tant genetic information that is relevant to the more common 
sporadic IS patients.  
 
Table 3.  Clinical and Demographic Comparison of Multiplex 
and Simplex IS Families with Atleast 4 Members 
Ethnicity was determined by self-report of parental origin. Cobb 
angles were maximum measurements recorded prior to correction 
(caw, jah previously unpublished data).  
 Multiplex  Simplex 
% non-European  9  8 
% male probands  18  17 
Age at 1
st presentation (std dev)  11.7 (+/-2.9)  12.1 (+/-2.8) 
Cobb angle (median)  40.3˚ (39˚) 42.1˚ (42˚) 
 
FUTURE WORK  
  In the near term we expect that genomic studies will dis-
cover factors with strongest effects on susceptibility to IS, 
revealing insights into disease pathogenesis. An important 
question will be how such factors, separately and together, 
contribute quantitatively to risk of disease (so-called popula-
tion attributable risk, or PAR). Quantitative analyses and 
stratification of such datasets may also enable better defini-
tion of clinical subtypes within the diagnoses. Identification 
of genetic factors underlying these diseases will enable fur-
ther research enhancing the prospect for alternative, less in-
vasive therapies. 
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